Physician profile
Ashlee Page
NPI 1386374346
$3,945.45
in general payments reported to CMS, 2019-2025
25 companies · $837 in 2025
The $837 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,235 · 2023: $828 · 2024: $1,045 · 2025: $837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,709.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $1,235.48 | 2022 | |
| Novo Nordisk INC | $486.89 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $400.21 | 2023-2025 | |
| Abbvie INC. | $382.19 | 2023-2025 | |
| Lilly USA, LLC | $341.67 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $176.56 | 2023-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Glaxosmithkline, LLC. | $131.55 | 2023-2025 | Shingrix, Arexvy |
| Amgen INC. | $111.31 | 2023-2025 | Evenity, Prolia, Otezla |
| Phathom Pharmaceuticals, INC. | $99.38 | 2024-2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $84.84 | 2023-2025 | Airsupra, Farxiga |
| Mayne Pharma Commercial LLC | $62.96 | 2025 | |
| Idorsia Pharmaceuticals US INC | $62.08 | 2023 | Quviviq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.81 | 2025 | Ofev |
| Organon LLC | $49.34 | 2023-2025 | Nexplanon |
| Phadia US INC. | $42.29 | 2024-2025 | Immunocap |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $40.99 | 2023-2024 | Cologuard Collection Kit |
| Teleflex LLC | $27.73 | 2025 | Barrigel |
| Hologic Sales and Service, LLC | $26.25 | 2025 | Aptima |
| Astellas Pharma US INC | $25.15 | 2024 | Veozah |
| Exeltis, USA INC. | $23.39 | 2023 | Slynd |
| Impel Pharmaceuticals INC. | $22.63 | 2023 | Trudhesa |
| Bayer Healthcare Pharmaceuticals INC. | $18.38 | 2024 | |
| Edwards Lifesciences Corporation | $17.33 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Tolmar, INC. | $13.78 | 2025 | Jatenzo |
| Seqirus USA INC | $13.26 | 2024 | Flucelvax, Fluad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlee Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.